IP Library Granted Patent US 7,736,292
Granted Patent B2
US 7,736,292 · App. 11/554,731 · Granted Jun 15, 2010

Brachytherapy apparatus and methods of using same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,736,292
App. No.
11/554,731
Granted
Jun 15, 2010
Kind
B2
Abstract

Apparatus, systems and methods for delivering brachytherapy to a target tissue region of a human or other mammalian body. In some embodiments, a flexible brachytherapy device is implanted that includes a therapy delivery portion having one or more radioactive sources securely retained thereto, and a tail portion extending from the therapy delivery portion. Once implanted, the tail portion may extend outside the body, where it may be folded and secured flat against the skin. The device may be removed at therapy completion. Other embodiments of the invention are directed to systems and methods for delivering brachytherapy devices to the body.

Claims (61)

1. A brachytherapy treatment device operable for implantation into a target tissue region of a body, the device comprising:

a therapy delivery portion comprising two or more radioactive sources enclosed and constrained from movement within a casing such that through holes extending through the radioactive sources are aligned with one another; and

at least one non-dissolving flexible tail portion extending from the therapy delivery portion and operable to extend outside the body after implantation of the device, the tail portion comprising a device hub with a protrusion that extends into the casing to at least partially define a lumen that extends through the tail portion and the through holes to an opening in a distal end of the casing, the lumen sized for receiving a needle therethrough.

2. The device of claim 1 , wherein the casing comprises heat-shrinkable tubing.

3. The device of claim 1 , wherein the casing comprises:

a first layer formed from a meltable first material capable of encapsulating the one or more radioactive sources; and

a second layer surrounding the first layer, the second layer formed from a heat-shrinkable material.

4. The device of claim 1 , wherein the therapy delivery portion further comprising one or more hollow spacers provided between adjacent radioactive sources, the hollow spacers comprising through holes further defining the lumen.

5. The device of claim 1 , wherein the device hub comprises a connector for engaging a cooperating connector on a needle received within the lumen to releasably engage the needle with the device hub.

6. The device of claim 1 , wherein the protrusion is captured by the casing to attach the device hub to the therapy delivery portion.

7. The device of claim 6 , wherein the protrusion comprises barbs for securing the device hub to the casing.

8. A brachytherapy treatment device operable for implantation into a target region of breast tissue, the device comprising:

a non-dissolving flexible tail portion comprising a hub with a protrusion;

a therapy delivery portion extending from the tail portion and comprising:

a) two or more radioactive seeds, each seed defined by a first end, a second end and a lumen spanning between the first end and the second end;

b) a hollow spacer located between the two or more radioactive seeds; and

c) a tubular casing surrounding and constraining the two or more radioactive seeds, the spacer, and the protrusion from movement such that the seeds and spacer are aligned to at least partially define a lumen extending from the tail portion through the protrusion and seed lumens to an opening in a distal end of the casing.

9. A kit for delivering brachytherapy to a target region of breast tissue, the kit comprising:

a removably implantable elongate brachytherapy device comprising:

a therapy delivery portion comprising one or more radioactive seeds, wherein each seed defines a through hole;

a casing enclosing and constraining the one or more radioactive seeds from movement; and

a device hub comprising a protrusion that extends into the casing such that a lumen is defined that extends through the device hub, the protrusion, and the through hole of each of the one or more radioactive seeds to an opening in a distal end of the casing; and

a needle removably insertable through the lumen defined by the one or more radioactive seeds, the casing, and the device hub such that a sharp tip of the needle extends beyond the distal end of the casing.

10. The kit of claim 9 , further comprising an elongate removal tool selectively insertable through the lumen defined by the one or more radioactive seeds, the casing, and the device hub after removing the needle, wherein the removal tool comprises a removal tool hub selectively engageable with the device hub.

11. The kit of claim 10 , wherein the removal tool comprises a lock for engaging the removal tool with the device hub.

12. The kit of claim 9 , wherein the protrusion is captured by the casing.

13. The kit of claim 9 , wherein the one or more radioactive seeds comprise a plurality of radioactive seeds comprising through holes, the casing enclosing the seeds such that the through holes are aligned with one another to at least partially define the lumen.

14. The kit of claim 13 , wherein the therapy delivery portion further comprising one or more hollow spacers provided between adjacent radioactive seeds, the hollow spacers comprising through holes further defining the lumen.

15. The kit of claim 9 , wherein the needle comprises a lock for releasably engaging the needle with the device hub.

16. The kit of claim 9 , wherein the distal end of the casing is shaped to provide a smooth transition from the needle to the therapy deliver portion when the needle is inserted into the lumen.

17. A method of providing brachytherapy to a target region of breast tissue within a body, the method comprising:

inserting a needle through a lumen of an elongate brachytherapy device until a sharp tip of the needle extends beyond the device, the device comprising a therapy delivery portion having two or more radioactive sources surrounded and restrained by a tubular casing, the radioactive sources comprising through holes at least partially defining the lumen;

introducing the needle and device into the target region; and

removing the needle from the device and leaving the device implanted within the target region for a period of about four or more days.

18. The method of claim 17 , further comprising removing the brachytherapy device from the target region.

19. The method of claim 17 , wherein the sharp tip penetrates tissue when the needle and device are introduced into the target region.

20. The method of claim 17 , wherein the tail portion comprises a device hub attached to the therapy delivery portion, and wherein inserting the needle through the elongate brachytherapy device comprises engaging a lock on the needle with the device hub.

21. The method of claim 20 , further comprising disengaging the lock on the needle from the device hub before removing the needle from the device.

22. The method of claim 17 , further comprising:

inserting a removal tool into the lumen of the device after leaving the device implanted within the target region; and

removing the removal tool and device from the target region.

23. The method of claim 22 , wherein the tail portion comprises a device hub attached to the therapy delivery portion, wherein removing the removal tool and device comprises:

coupling the removal tool to the device hub; and

removing the removal tool, thereby removing the device from the target region.

24. A method of providing brachytherapy to a target region of breast tissue within a body, the method comprising:

coupling an elongate brachytherapy device to a needle by inserting the needle into a lumen of the device, the device comprising:

a therapy delivery portion comprising one or more radioactive sources; and

a casing surrounding and restraining the one or more radioactive sources, each radioactive source comprising a through hole at least partially defining the lumen;

inserting the needle and associated brachytherapy device into the breast tissue;

immobilizing the brachytherapy device; and

withdrawing the needle from the breast tissue, whereby the brachytherapy device remains implanted.

25. The method of claim 24 , wherein inserting the needle and associated brachytherapy device into the breast tissue comprises implanting the brachytherapy device within or proximate a lumpectomy cavity.

26. The method of claim 24 , wherein the needle comprises a sharp distal tip that extends beyond a distal end of the therapy delivery portion when the device is coupled to the needle, the sharp tip penetrating tissue when the needle and associated brachytherapy device are inserted into the breast tissue.

27. The method of claim 24 , wherein the tail portion comprises a device hub attached to the therapy delivery portion and wherein coupling an elongate brachytherapy device to the needle comprises engaging a lock on the needle with the device hub.

28. The method of claim 27 , further comprising disengaging the lock on the needle from the device hub before withdrawing the needle from the breast tissue.

29. The method of claim 24 , further comprising:

inserting a removal tool into the lumen of the device after leaving the device implanted within the target region; and

removing the removal tool and device from the target region.

30. The method of claim 29 , wherein the tail portion comprises a device hub attached to the therapy delivery portion, wherein removing the removal tool and device comprises:

coupling the removal tool to the device hub; and

removing the removal tool, thereby removing the device from the target region.

Assignments (8)
SECURITY INTEREST Recorded Jan 5, 2021
From: CIANNA MEDICAL, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 054813/0661 →
RELEASE OF SECURITY INTEREST Recorded Nov 14, 2018
From: SOLAR CAPITAL LTD.
To: CIANNA MEDICAL, INC.
Reel/Frame 047505/0212 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 9, 2016
From: CIANNA MEDICAL, INC.
To: SOLAR CAPITAL LTD., AS COLLATERAL AGENT
Reel/Frame 040581/0215 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
PATENT SECURITY AGREEMENT Recorded Jul 29, 2008
From: BIOLUCENT, INC.
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021311/0079 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2008
From: BIOLUCENT, INC.
To: CIANNA MEDICAL, INC.
Reel/Frame 020655/0287 →
PATENT SECURITY AGREEMENT Recorded Oct 26, 2007
From: BIOLUCENT, INC.
To: GOLDMAN SACHS CREDIT PARTNERS L.P.
Reel/Frame 020024/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2007
From: HERMANN, GEORGE D.; SUTTON, DOUG S.; LEBOVIC, GAIL S.; SING, EDUARDO CHI; BOWES, ROBERT R.
To: BIOLUCENT, INC.
Reel/Frame 019087/0097 →